The 2024 Les Turner Symposium on ALS will be held on Monday, Nov. 4 in Chicago. Hosted by the Les Turner ALS Foundation and the Les Turner ALS Center at Northwestern Medicine, this event will assemble internationally-renowned ALS researchers, clinicians, advocates, and people living with ALS to discuss the latest research and perspectives on the disease.
The keynote address, Advances in ALS Clinical Trial Outcome Measures, will be delivered by Angela Genge, MD, FRCP(C). Dr. Genge is widely recognized for her work in clinical trial design and development for rare neurological conditions.
Since 1998, she has served as director of the ALS Global Center of Excellence and ALS Clinic at the Montreal Neurological Institute and Hospital. During her twenty-year tenure as executive director of the Institute's clinical research unit, over 100 clinical trials were conducted from Phase 1 to Phase 4, making it the most active neuroscience unit in Canada. Dr.
Genge has been a pioneer in bringing ALS clinical trials to Canada. Over her long career, she has played an important role in clinical trial design, with a recent focus on the role of biomarkers in ALS therapeutic development. Beyond that, she is an amazing clinician dedicated to her patients and an outstanding mentor to junior faculty interested in ALS clinical research.
" Senda Ajroud-Driss, MD, Director, Lois Insolia ALS Clinic at the Les Turner ALS Center, Northwestern Medicine She will be joined by researchers from London's UCL Que.